Prevalence of SARS-CoV-2 RNA on inanimate surfaces: a systematic review and meta-analysis. 2021

Simone Belluco, and Marzia Mancin, and Filippo Marzoli, and Alessio Bortolami, and Eva Mazzetto, and Alessandra Pezzuto, and Michela Favretti, and Calogero Terregino, and Francesco Bonfante, and Roberto Piro
Department of Food Safety, Istituto Zooprofilattico Sperimentale Delle Venezie, Legnaro, Italy. sbelluco@izsvenezie.it.

Coronavirus disease (COVID-19) is a respiratory disease affecting many people and able to be transmitted through direct and perhaps indirect contact. Direct contact transmission, mediated by aerosols or droplets, is widely demonstrated, whereas indirect transmission is only supported by collateral evidence such as virus persistence on inanimate surfaces and data from other similar viruses. The present systematic review aims to estimate SARS-CoV-2 prevalence on inanimate surfaces, identifying risk levels according to surface characteristics. Data were obtained from studies in published papers collected from two databases (PubMed and Embase) with the last search on 1 September 2020. Included studies had to be papers in English, had to deal with coronavirus and had to consider inanimate surfaces in real settings. Studies were coded according to our assessment of the risk that the investigated surfaces could be contaminated by SARS-CoV-2. A meta-analysis and a metaregression were carried out to quantify virus RNA prevalence and to identify important factors driving differences among studies. Thirty-nine out of forty retrieved paper reported studies carried out in healthcare settings on the prevalence of virus RNA, five studies carry out also analyses through cell culture and six tested the viability of isolated viruses. Overall prevalences of SARS-CoV-2 RNA on high-, medium- and low-risk surfaces were 0.22 (CI95 [0.152-0.296]), 0.04 (CI95 [0.007-0.090]), and 0.00 (CI95 [0.00-0.019]), respectively. The duration surfaces were exposed to virus sources (patients) was the main factor explaining differences in prevalence.

UI MeSH Term Description Entries
D004866 Equipment Contamination The presence of an infectious agent on instruments, prostheses, or other inanimate articles. Contamination, Equipment,Contaminations, Equipment,Equipment Contaminations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences
D050296 Microbial Viability Ability of a microbe to survive under given conditions. This can also be related to a colony's ability to replicate. Bacterial Viability,Virus Viability,Bacteria Viability,Microbial Inactivation,Inactivation, Microbial,Viability, Bacteria,Viability, Bacterial,Viability, Microbial,Viability, Virus
D050456 Fomites Inanimate objects that carry pathogenic microorganisms and thus can serve as the source of infection. Microorganisms typically survive on fomites for minutes or hours. Common fomites include CLOTHING, tissue paper, hairbrushes, and COOKING AND EATING UTENSILS. Fomite

Related Publications

Simone Belluco, and Marzia Mancin, and Filippo Marzoli, and Alessio Bortolami, and Eva Mazzetto, and Alessandra Pezzuto, and Michela Favretti, and Calogero Terregino, and Francesco Bonfante, and Roberto Piro
July 2023, Microbiological research,
Simone Belluco, and Marzia Mancin, and Filippo Marzoli, and Alessio Bortolami, and Eva Mazzetto, and Alessandra Pezzuto, and Michela Favretti, and Calogero Terregino, and Francesco Bonfante, and Roberto Piro
June 2022, Journal of clinical nursing,
Simone Belluco, and Marzia Mancin, and Filippo Marzoli, and Alessio Bortolami, and Eva Mazzetto, and Alessandra Pezzuto, and Michela Favretti, and Calogero Terregino, and Francesco Bonfante, and Roberto Piro
August 2023, Scientific reports,
Simone Belluco, and Marzia Mancin, and Filippo Marzoli, and Alessio Bortolami, and Eva Mazzetto, and Alessandra Pezzuto, and Michela Favretti, and Calogero Terregino, and Francesco Bonfante, and Roberto Piro
November 2020, Scientific reports,
Simone Belluco, and Marzia Mancin, and Filippo Marzoli, and Alessio Bortolami, and Eva Mazzetto, and Alessandra Pezzuto, and Michela Favretti, and Calogero Terregino, and Francesco Bonfante, and Roberto Piro
December 2022, International journal of environmental research and public health,
Simone Belluco, and Marzia Mancin, and Filippo Marzoli, and Alessio Bortolami, and Eva Mazzetto, and Alessandra Pezzuto, and Michela Favretti, and Calogero Terregino, and Francesco Bonfante, and Roberto Piro
May 2024, Microbes and infection,
Simone Belluco, and Marzia Mancin, and Filippo Marzoli, and Alessio Bortolami, and Eva Mazzetto, and Alessandra Pezzuto, and Michela Favretti, and Calogero Terregino, and Francesco Bonfante, and Roberto Piro
December 2020, ACS applied materials & interfaces,
Simone Belluco, and Marzia Mancin, and Filippo Marzoli, and Alessio Bortolami, and Eva Mazzetto, and Alessandra Pezzuto, and Michela Favretti, and Calogero Terregino, and Francesco Bonfante, and Roberto Piro
March 2021, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
Simone Belluco, and Marzia Mancin, and Filippo Marzoli, and Alessio Bortolami, and Eva Mazzetto, and Alessandra Pezzuto, and Michela Favretti, and Calogero Terregino, and Francesco Bonfante, and Roberto Piro
January 2020, Frontiers in public health,
Simone Belluco, and Marzia Mancin, and Filippo Marzoli, and Alessio Bortolami, and Eva Mazzetto, and Alessandra Pezzuto, and Michela Favretti, and Calogero Terregino, and Francesco Bonfante, and Roberto Piro
August 2021, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!